Skip to content

MoonLake Immunotherapeutics MLTX Other Non-Current Assets

Other Non-Current Assets at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$103K0.0%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$256K0.0%
Opko Health logo
Opko HealthOPK
$18.9M+0.7%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$11.24M+108%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$93K-88.7%
Eli Lilly logo
Eli LillyLLY

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.49B-45.9%
Enterprise value$1.29B-50.0%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MoonLake Immunotherapeutics's other non-current assets?
MoonLake Immunotherapeutics (MLTX) reported other non-current assets of $1.34M in Q1 2026.
How has MoonLake Immunotherapeutics's other non-current assets changed year-over-year?
MoonLake Immunotherapeutics's other non-current assets decreased by 20.8% year-over-year, from $1.7M to $1.34M.
What does other non-current assets mean?
This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.